ZG005 for Injection Clinical Trials

4 actively recruiting trials

No change since May 2026

Also known as: ZG005

Pipeline

Phase 2: 1Phase 1/2: 3

Top Sponsors

Suzhou Zelgen Biopharmaceuticals Co.,Ltd4

Indications

Cancer4
Lung Cancer2
Liver Disease1
Advanced Solid Tumor1
Lymphoma1

Other4 trials

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1/2

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

Phase 1/2

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.